incretina glp 1 The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes Incretin-based therapy of metabolic disease

Several studies indicate that the early lesions occur at the level of the optical nerve, in particular, in the proximity of the head of the optic nerve at the level of the lamina cribrosa

Type 1 diabetes is an autoimmune disease that often develops early in life

Effects of mindfulness- and acceptance-based interventions on diabetes distress and glycaemic level in people with type 2 diabetes: systematic review and meta-analysis

Common side effects of this medication are nausea, vomiting, diarrhea, dizziness, etc

All GLP-1 agonist receptors, including, Wegovy have common side effects like heartburn, constipation, diarrhea, nausea, and an upset stomach